• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示癌症患者口腔黏膜炎的多方面管理:一项叙述性综述

Unveiling the Multifaceted Management of Oral Mucositis in Cancer Patients: A Narrative Review.

作者信息

R Sangavi, Pandiyan Indumathy

机构信息

Department of Oral Medicine, Radiology, and Special Care Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, IND.

Department of Public Health Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

出版信息

Cureus. 2024 Feb 29;16(2):e55213. doi: 10.7759/cureus.55213. eCollection 2024 Feb.

DOI:10.7759/cureus.55213
PMID:38558646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10981506/
Abstract

Oral mucositis (OM) is a major and common adverse reaction to cancer treatment, occurring in all patients who undergo radiation therapy or chemotherapy that includes the mucosal areas of the oral and oropharyngeal region. The pathophysiology of OM remains incompletely understood, and there are many unanswered questions about the risk factors for developing OM. Multidisciplinary clinicians and researchers must collaborate to better understand and expand treatment strategies for OM and other inflammatory conditions in oncology. This will lead to the development of more effective treatments and reduce the burden of OM in cancer patients. This article comprehensively reviews the risk factors and patient factors associated with OM, its pathogenesis, clinical presentation, grading, and management.

摘要

口腔黏膜炎(OM)是癌症治疗中一种主要且常见的不良反应,发生于所有接受包括口腔和口咽区域黏膜部位的放射治疗或化疗的患者。OM的病理生理学仍未完全明确,关于发生OM的风险因素仍有许多未解答的问题。多学科临床医生和研究人员必须合作,以更好地理解并扩展针对OM及肿瘤学中其他炎症性疾病的治疗策略。这将促成更有效的治疗方法的开发,并减轻癌症患者的OM负担。本文全面综述了与OM相关的风险因素和患者因素、其发病机制、临床表现、分级及管理。

相似文献

1
Unveiling the Multifaceted Management of Oral Mucositis in Cancer Patients: A Narrative Review.揭示癌症患者口腔黏膜炎的多方面管理:一项叙述性综述
Cureus. 2024 Feb 29;16(2):e55213. doi: 10.7759/cureus.55213. eCollection 2024 Feb.
2
Current Trends in Management of Oral Mucositis in Cancer Treatment.癌症治疗中口腔黏膜炎管理的当前趋势
Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2019-2026. doi: 10.22034/APJCP.2017.18.8.2019.
3
Recent advances in cancer therapy-associated oral mucositis.癌症治疗相关口腔黏膜炎的最新进展
Oral Dis. 2024 Jul 5. doi: 10.1111/odi.14999.
4
Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers.WHO、RTOG 和 CTCAE v4.0 分级标准评估头颈部癌症放化疗相关性口腔黏膜炎的一致性。
Support Care Cancer. 2021 Oct;29(10):6061-6068. doi: 10.1007/s00520-021-06177-x. Epub 2021 Mar 31.
5
Proposal of a prophylactic photobiomodulation protocol for chemotherapy-induced oral and oropharyngeal mucositis: a randomized clinical trial.预防性光生物调节方案预防化疗引起的口腔和口咽黏膜炎的随机临床试验提案。
Lasers Med Sci. 2023 Oct 27;38(1):245. doi: 10.1007/s10103-023-03916-w.
6
Evaluation of current and upcoming therapies in oral mucositis prevention.评估当前和即将出现的口腔黏膜炎预防疗法。
Future Oncol. 2010 Nov;6(11):1751-70. doi: 10.2217/fon.10.133.
7
Adverse event management of oral mucositis in patients with breast cancer.乳腺癌患者口腔黏膜炎的不良事件管理
Breast Care (Basel). 2014 Apr;9(4):232-7. doi: 10.1159/000366246.
8
A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients.一项系统评价和荟萃分析,评估低水平激光疗法(LLLT)对儿科和年轻患者化疗诱导性口腔黏膜炎的疗效。
Eur J Pediatr. 2018 Jan;177(1):7-17. doi: 10.1007/s00431-017-3043-4. Epub 2017 Nov 11.
9
Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis.口腔-肠道微生物群轴在癌症治疗引起的口腔黏膜炎发病机制中的作用
Front Oral Health. 2022 Mar 28;3:881949. doi: 10.3389/froh.2022.881949. eCollection 2022.
10
Patient perceptions about chemotherapy-induced oral mucositis: implications for primary/secondary prophylaxis strategies.患者对化疗引起的口腔黏膜炎的认知:对一级/二级预防策略的启示
Support Care Cancer. 2004 Jul;12(7):526-30. doi: 10.1007/s00520-004-0640-3. Epub 2004 May 19.

引用本文的文献

1
Recent advances in oral cryotherapy for the management of anticancer therapy-induced oral mucositis.口腔冷冻疗法在抗癌治疗所致口腔黏膜炎管理中的最新进展。
Future Sci OA. 2025 Dec;11(1):2527500. doi: 10.1080/20565623.2025.2527500. Epub 2025 Jul 3.
2
Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology.药物遗传学对儿童肿瘤学中高剂量甲氨蝶呤毒性的影响。
Pharmaceutics. 2025 Apr 29;17(5):585. doi: 10.3390/pharmaceutics17050585.
3
Huoshan Dendrobium Zengye Jiedu Formula mitigates radiation-induced oral mucositis and improves oral immune microenvironment by targeting the EGFR/PI3K/AKT pathway: evidence from network pharmacology, molecular docking, and experimental validation.

本文引用的文献

1
Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses.口服和局部抗氧化剂在预防和治疗头颈部癌症患者口腔粘膜炎中的疗效:系统评价和荟萃分析。
Support Care Cancer. 2022 Nov;30(11):8689-8703. doi: 10.1007/s00520-022-07190-4. Epub 2022 Jun 10.
2
The Benefit of Zinc Sulfate in Oropharyngeal Mucositis during Hyperfractionated Accelerated Concomitant Boost Radiotherapy with Concurrent Cisplatin for Advanced-Stage Oropharyngeal and Hypopharyngeal Cancers.硫酸锌在晚期口咽癌和下咽癌同步顺铂超分割加速同期增量放疗期间对口咽黏膜炎的益处
Indian J Palliat Care. 2020 Oct-Dec;26(4):437-443. doi: 10.4103/IJPC.IJPC_20_20. Epub 2020 Nov 19.
3
霍山石斛增液解毒方通过靶向EGFR/PI3K/AKT通路减轻放射性口腔黏膜炎并改善口腔免疫微环境:来自网络药理学、分子对接和实验验证的证据
Front Immunol. 2025 Mar 10;16:1559400. doi: 10.3389/fimmu.2025.1559400. eCollection 2025.
4
A longitudinal assessment of major mouthwashes used in alleviating pain and xerostomia among advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy.一项针对接受放化疗的晚期鼻咽癌患者使用主要漱口水缓解疼痛和口干情况的纵向评估。
J Oncol Pharm Pract. 2024 Aug 2;31(6):10781552241265933. doi: 10.1177/10781552241265933.
MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients.MASCC/ISOO 临床实践指南:口腔黏膜炎管理-儿科癌症患者口腔黏膜炎管理当前干预措施的亚分析。
Support Care Cancer. 2021 Jul;29(7):3539-3562. doi: 10.1007/s00520-020-05803-4. Epub 2020 Nov 6.
4
Oral mucositis: the hidden side of cancer therapy.口腔黏膜炎:癌症治疗的隐匿面。
J Exp Clin Cancer Res. 2020 Oct 7;39(1):210. doi: 10.1186/s13046-020-01715-7.
5
Management of Cancer Therapy-Associated Oral Mucositis.癌症治疗相关口腔黏膜炎的管理。
JCO Oncol Pract. 2020 Mar;16(3):103-109. doi: 10.1200/JOP.19.00652. Epub 2020 Feb 3.
6
Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines.系统评价癌症患者口腔黏膜炎管理中抗炎药物的应用及临床实践指南。
Support Care Cancer. 2019 Oct;27(10):3985-3995. doi: 10.1007/s00520-019-04888-w. Epub 2019 Jul 8.
7
Natural agents in the management of oral mucositis in cancer patients-systematic review.癌症患者口腔黏膜炎管理中的天然制剂——系统评价
J Oral Biol Craniofac Res. 2018 Sep-Dec;8(3):245-254. doi: 10.1016/j.jobcr.2017.12.003. Epub 2017 Dec 6.
8
Radiation-Induced Oral Mucositis.放射性口腔黏膜炎
Front Oncol. 2017 May 22;7:89. doi: 10.3389/fonc.2017.00089. eCollection 2017.
9
Pharmacotherapy for the management of cancer regimen-related oral mucositis.用于管理癌症治疗方案相关口腔黏膜炎的药物治疗。
Expert Opin Pharmacother. 2016 Sep;17(13):1801-7. doi: 10.1080/14656566.2016.1217993. Epub 2016 Aug 3.
10
Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?低强度激光疗法:头颈部癌症患者癌症治疗引起的口腔黏膜炎的支持性护理标准?
Laser Ther. 2012 Dec 26;21(4):297-303. doi: 10.5978/islsm.12-RE-01.